Er Therapeutics Stock Today
| PNGM Stock | USD 0.0001 0.00 0.000003% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Er Therapeutics is selling at 9.9999997E-5 as of the 19th of March 2025; that is 0 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Er Therapeutics has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain Materials | Category Basic Materials |
Pengram Corporation, an exploration stage mining company, engages in the acquisition, exploration, and development of natural resource properties, primarily gold. Pengram Corporation was founded in 2006 and is based in Bellingham, Washington. Pengram Corp operates under Other Industrial Metals Mining classification in the United States and is traded on OTC Exchange.. The company has 58.26 M outstanding shares. More on Er Therapeutics
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
PNGM Stock Highlights
| CEO | Richard Donaldson | |||||||||||||||||||||||||||||||||||
| Business Concentration | Diversified Metals & Mining, Other Industrial Metals & Mining, Basic Materials, Materials, Metals & Mining, Other Industrial Metals & Mining, Basic Materials (View all Sectors) | |||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Er Therapeutics (PNGM) is traded on OTCCE Exchange in USA and employs 1 people. Er Therapeutics is listed under Diversified Metals & Mining category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 332.11 K. Er Therapeutics conducts business under Metals & Mining sector and is part of Materials industry. The entity has 58.26 M outstanding shares.
Er Therapeutics currently holds about 650 in cash with (161.43 K) of positive cash flow from operations.
Check Er Therapeutics Probability Of Bankruptcy
PNGM Stock Against Markets
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Er Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in PNGM Stock, please use our How to Invest in Er Therapeutics guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Diversified Metals & Mining space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Er Therapeutics. If investors know PNGM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Er Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.95) |
The market value of Er Therapeutics is measured differently than its book value, which is the value of PNGM that is recorded on the company's balance sheet. Investors also form their own opinion of Er Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Er Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Er Therapeutics' market value can be influenced by many factors that don't directly affect Er Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Er Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Er Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Er Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.